Folate (folica acid) can bind selectively to folate receptor found in a broad spectrum of cancer tissues, such as cancers of the ovary, lung, endometrium, kidney, breast, bladder, and brain. Folate-polyPEG can be used to design nanoparticles-based targeted cancer therapy via folate receptor which minimizes nonspecific uptake in normal cells.